Publications
-
1.
2013Eric D. Horowitz; K. Shefaet Rahman; Brian D. Bower; David J. Dismuke; Michael R. Falvo; Jack D. Griffith; Stephen C. Harvey; Aravind Asokan
Journal of Virology. 2013;87(6):2994-3002. -
2.
2012Shen Shen; Kelli D. Bryant; Junjiang Sun; Sarah M. Brown; Andrew Troupes; Nagesh Pulicherla; Aravind Asokan
Glycan binding avidity determines the systemic fate of adeno- associated virus type 9
Journal of Virology. 2012;86(19):10408-10417. -
3.
2012Jerome Denard; Cyriaque Beley; Robert Kotin; René Lai-Kuen; Stéphane Blot; Hervé Leh; Aravind Asokan; R. Jude Samulski; Philippe Moullier; Thomas Voit; et al.
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
Journal of Virology. 2012;86(12):6620-6631.
Similar Experts
- Publications
- 163
- 81
- 23
- 406
- 55
Journals
-
Publications
-
9
-
5
-
4
-
2
-
2
Grants
-
1.
Richard Samulski; Aravind Asokan; Joshua Grieger; Chengwen Li; Paul Monahan; Dougald Monroe; Timothy Nichols; Roland Tisch
Neutralizing Antibody and AAV FIX Gene Therapy
2/8/2013 - 1/31/2018
Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI)
Funding: $ 2,189,400.00
-
2.
Richard Superfine; Aravind Asokan; Richard Boucher; Keith Burridge; Claire Doerschuk; Michael Falvo; Kenneth Jacobson; Susan Lord
Nanomanipulation system for Biomedical Research and Development
2/2/2012 - 1/31/2013
Sponsor: North Carolina Biotechnology Center (NCBC)
Funding: $ 165,473.00
-
3.
Aravind Asokan
Determinants of AAV Lung Tropism ARRA
12/12/2008 - 11/30/2013
Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI)
Funding: $ 219,040.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
23
-
8
-
5
-
4
-
4
-
1
-
External OrganizationsShared Pub.
-
8
-
4
-
1
-
1
-
1
-
1

